Cyclosporiasis Spreads Through Five States' Taco Bell Lettuce

Taco Bell's iceberg lettuce has cyclospora in it—five states, Indiana through West Virginia. The company pulled the product while health agencies issued alerts.

By tomorrow the news cycle will move on. The question that stays unasked is why this keeps happening to the same supply chains, solved the same way each time. Then happens again.

Twenty years ago, a spinach outbreak killed three people and sickened 200 in September 2006—E. coli that triggered what looked like genuine reckoning. The FDA and produce industry built traceability protocols, mapped supply chains backward to farms and forward to registers, installed testing regimens.

By 2015 it hadn't been. The protocols remained but compliance became optional—the kind of optional that happens when solutions cost money and nobody is dying this quarter. Testing got lighter, farms consolidated, and traceability theater replaced actual traceability. Then in 2018, romaine lettuce contaminated with listeria moved through the exact same distribution systems, hit the exact same retail networks. Sickened people in exactly the same pattern the spinach outbreak had predicted.

This isn't a failure of technology or knowledge—it's a failure of incentive structure. A produce company faces a choice. They can spend real money on testing every batch, or they can spend less and accept a small probability of outbreak litigation. Do that math across 10,000 farms and a thousand distribution points, and the economics scream the same answer every time. The outbreak happens, lawsuits settle, regulations tighten for 18 months, then the pressure releases and the cycle restarts. What matters now is whether the financial incentive to cut corners during quiet years has actually changed since 2018.

Watch whether new traceability mandates come with funding, enforcement mechanisms, and penalties that exceed the cost of compliance. If they don't, you're watching an institution convince itself it solved a problem while guaranteeing the next outbreak. You've already seen this decision cycle in your own work—the moment when cutting the expensive step seems reasonable because the consequence feels distant.